预填充式注射器市场规模、份额、成长分析，按类型、按设计、按材料、按应用、按地区 - 行业预测，2024-2031 年

2022年全球预填充式注射器市场规模将为68亿美元，从2023年的75.2亿美元成长到2031年的168.4亿美元，预测期间（2024-2031年）预计复合年增长率为10.60%。

预填充式注射器市场的成长主要是由于对高效且用户友好的给药系统的需求不断增长以及医疗保健专业人员为减少医院错误而做出的努力所推动的。促成这一市场扩张的因素包括居家医疗服务的增加、注射药物使用的增加、慢性病患病率的增加以及预填充式注射器相对于传统管瓶的优势。预填充式注射器的技术进步在支援市场成长方面也发挥着重要作用。然而，它面临着替代医疗保健提供方法的可用性、严格的政府法规和产品召回等挑战，这可能会阻碍市场扩张。相反，生技药品和生物相似药的发展，以及预填充注射剂需求的不断增长，为该行业的未来成长提供了良好的机会。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价格分析
• 价值链分析
• 市场生态系统
• 贸易分析
• 供应链分析
• 案例研究分析
• 专利分析
• 客户和购买标准分析
• 监管环境
• 创新矩阵
• 重点投资分析
• 关键成功因素
• 竞争程度

预填充式注射器市场：依类型

• 市场概况
• 传统预填充式注射器
  • 一次性预填充式注射器
  • 可重复使用的预填充式注射器
• 安全预填充式注射器

预填充式注射器市场：设计

• 市场概况
• 单室预填充式注射器
• 双腔室预填充式注射器
• 客製化预填充式注射器

预填充式注射器市场：依材料分类

• 市场概况
• 玻璃预填充式注射器
• 塑胶预填充式注射器

预填充式注射器市场：依应用分类

• 市场概况
• 糖尿病
• 类风湿性关节炎
• 过敏反应
• 癌症
• 血栓症
• 眼科
• 其他的

预填充式注射器市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• BD（US）
• Gerresheimer AG（Germany）
• SCHOTT（Germany）
• West Pharmaceutical Services, Inc.（US）
• AptarGroup, Inc.（US）
• Nipro（Japan）
• Baxter（Simtra）（US）
• Owen Mumford Ltd.（UK）
• Weigao Medical International Co., Ltd.（China）
• Credence MedSystems, Inc.（US）
• Novartis AG（Switzerland）
• Stevanato Group（Italy）
• Poly Medicure（India）
• MedXL Inc.（Canada）
• Sharps Technology, Inc.（US）
• Fresenius Kabi USA（US）
• Medefil, Inc.（US）
• DBMSRL（Italy）
• Taisei Kako Co., Ltd.（Japan）
• Shandong Province Medicinal Glass Co., Ltd.（China）
• Shin Yan Sheno Precision Industrial Co., Ltd.（Taiwan）
• JO Pharma Co., Ltd.（Otsuka Holdings Co., Ltd.）（Japan）
• BMI Korea（South Korea）
• Al Shifa Medical Products Co.（Saudi Arabia）

Global Prefilled Syringes Market size was valued at USD 6.8 billion in 2022 and is poised to grow from USD 7.52 billion in 2023 to USD 16.84 billion by 2031, growing at a CAGR of 10.60% during the forecast period (2024-2031).

The growth of the prefilled syringes market is primarily driven by increasing demand for efficient and user-friendly drug delivery systems, coupled with efforts by healthcare professionals to reduce hospital errors. Factors contributing to this market expansion include the rise in home healthcare services, the growing use of injectable medications, the higher prevalence of chronic diseases, and the benefits of prefilled syringes compared to traditional vials. Technological advancements in prefilled syringes also play a crucial role in supporting market growth. However, the market faces challenges such as the availability of alternative medicine delivery methods, stringent government regulations, and product recalls, which may hinder its expansion. Conversely, the development of biologics and biosimilars, along with the increasing demand for injectable medications in prefilled formats, offer promising opportunities for future growth in the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Prefilled Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Prefilled Syringes Market Segmental Analysis

Global Prefilled Syringes Market is segmented by Type, Design, Material, Application, and region. Based on Type, the market is segmented into Conventional Prefilled Syringes, and Safety Prefilled Syringes. Based on Design, the market is segmented into Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes. Based on Material, the market is segmented into Glass Prefilled Syringes, and Plastic Prefilled Syringes. Based on Application, the market is segmented into Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Prefilled Syringes Market

Prefilled syringes are commonly utilized for managing chronic conditions, enabling patients to self-administer their medications for diseases such as diabetes, heart disorders, and autoimmune conditions. The growing global prevalence of these chronic and life-threatening diseases is driving an expansion in the prefilled syringes market. Additionally, the increasing demand for self-injection devices is fueled by their convenience and safety, further contributing to the market's growth.

Restraints in the Global Prefilled Syringes Market

Global growth in the prefilled syringes market faces significant challenges, including product recalls, potential reactions between drugs and syringe components, and other related issues. A notable example occurred, when Novartis Pharmaceuticals UK recalled a batch of Lucentis 10 mg/ml injection solution due to a defect in the plunger stopper. This recall resulted in an uptick in customer complaints regarding difficulties in operating the plunger.

Market Trends of the Global Prefilled Syringes Market

Biologics and biosimilars are increasingly taking the place of chemical-based drugs in the global life science market. These biologics are favored for their targeted delivery capabilities and lower risk of drug interactions, leading to a growing preference for their use. Consequently, pharmaceutical and packaging manufacturers face pressure to innovate and develop advanced container closure and drug delivery systems. This shift has significantly boosted the adoption of prefilled syringes designed for the safe administration of biologics and biosimilars. For example, the Central Drugs Standard Control Organization (CDSCO) in India has approved 98 biosimilars to date, reflecting the expanding use and acceptance of these advanced treatments.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Prefilled Syringes Market by Type

• Market Overview
• Conventional Prefilled Syringes
  • Disposable Prefilled Syringes
  • Reusable Prefilled Syringes
• Safety Prefilled Syringes

Prefilled Syringes Market by Design

• Market Overview
• Single-chamber Prefilled Syringes
• Dual-chamber Prefilled Syringes
• Customized Prefilled Syringes

Prefilled Syringes Market by Material

• Market Overview
• Glass Prefilled Syringes
• Plastic Prefilled Syringes

Prefilled Syringes Market by Application

• Market Overview
• Diabetes
• Rheumatoid Arthritis
• Anaphylaxis
• Cancer
• Thrombosis
• Ophthalmology
• Others

Prefilled Syringes Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• BD (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCHOTT (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter (Simtra) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Weigao Medical International Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Credence MedSystems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poly Medicure (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedXL Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharps Technology, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi USA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medefil, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• D.B.M. S.R.L. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taisei Kako Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Province Medicinal Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shin Yan Sheno Precision Industrial Co., Ltd. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J.O. Pharma Co., Ltd. (Otsuka Holdings Co., Ltd.) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BMI Korea (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Al Shifa Medical Products Co. (Saudi Arabia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments